Clinical Trial Phases Explained: Phase 1 to Approval
Clinical trial phases explained: what happens in Phase 1, 2, 3 and 4, how each stage is designed, and how trial evidence supports FDA and EMA approval.
Preclinical research is the laboratory and animal work that has to support a candidate before any person is given it: pharmacology, toxicology, and the data that justify a starting dose in humans. Regulators authorise first-in-human testing on the strength of it, through an Investigational New Drug application in the United States or a clinical trial authorisation in the European Union.
This is also where a great many promising findings stop, and where results are most often reported as though they applied to people. Our coverage is explicit about the distance between a result in a model and a result in a patient.
Clinical trial phases explained: what happens in Phase 1, 2, 3 and 4, how each stage is designed, and how trial evidence supports FDA and EMA approval.
How new drugs are developed: target discovery, preclinical testing, clinical trials, regulatory review by FDA and EMA, manufacturing, and post-approval monitoring.
The drug development process from laboratory research to patients: translational research, decision gates, who does what, and how a medicine reaches clinical use.
Clinical trial phases in drug development: what evidence each phase produces, how go/no-go decisions are made, and how phases differ for biologics and vaccines.